Chun-Yuan Tu
Chun-Yuan Tu has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Bang-Hung Yang
National PET and Cyclotron Center (NPCC), Department of Nuclear Medicine, Taipei Veterans General Hospital, Taipei 112, Taiwan
1 shared publication Cheng-Han Wu
Taipei Med Univ, Shuang Ho Hosp, Dept Radiol, New Taipei, Taiwan
1 shared publicationJong-Ling Fuh
Taipei Vet Gen Hosp, Neurol Inst, Dept Neurol, Taipei, Taiwan
1 shared publicationTse-Hao Lee
Taipei Vet Gen Hosp, Dept Nucl Med, Taipei, Taiwan
1 shared publicationYueh-Hsun Lu
Taipei Med Univ, Shuang Ho Hosp, Dept Radiol, New Taipei, Taiwan
1 shared publicationYuh-Feng Wang
Taipei Vet Gen Hosp, Dept Nucl Med, Taipei, Taiwan
1 shared publication
Latest Publications
- Open Access
- 1 August 2023
- Published by AME Publishing Company in Quantitative Imaging in Medicine and Surgery
- Vol. 13 (8) , 4806-4815
Feasibility evaluation of middle-phase 18F-florbetaben positron emission tomography imaging using centiloid quantification and visual assessment
Background: 18F-florbetaben (FBB) positron emission tomography (PET) scan has been widely used in research and routine clinical practice. Most studies used late-phase (scanning from 90 to 110 min after injection) FBB scans to generate beta-amyloid accumulation data. The feasibility of middle-phase scan is seldom discussed. Using the middle-phase data can shorten the patients’ waiting between the injection and scan, and hospital can acquire more flexible schedule of routine scan. Methods: Paired middle-phase (60–80 min) FBB scans and standard (90–110 min) FBB scans were obtained from 27 subjects (12 neurodegenerative dementia, 8 mild cognitive impairment, 3 normal control, and 4 patients not suffering from neurodegenerative dementia). Standardized uptake value ratios (SUVRs) were calculated and converted to centiloid (CL) scale to investigate the impact on image quantification. CL pipeline validation were performed to build an equation converting the middle-phase data into equivalent standard scans. Cohen’s kappa of binary interpretation and brain amyloid plaque load (BAPL) score were also used to evaluate the intrareader agreement of the FBB image from the two protocols. Results: The middle-phase FBB SUVR showed an excellent correlation, which provided a linear regression equation of SUVRFBB60–80 = 0.88 × SUVRFBB90–110 + 0.07, with R2=0.98. The slope of the equation indicated that there was bias between the middle and standard acquisition. This can be converted into the CL scale using CL = 174.68 × SUVR − 166.39. Cohen’s kappa of binary interpretation and BAPL score were 1.0 (PConclusions: Our findings indicate that the middle-phase FBB protocol is feasible in clinical applications for scans that are at either end of beta-amyloid spectrum, which provides comparable semiquantitative results to standard scan. Patient’s waiting time between the injection and scan can be shortened.
- 1 August 2023
- Published by AME Publishing Company in Quantitative Imaging in Medicine and Surgery
- Vol. 13 (8) , 4806-4815
Open AccessFeasibility evaluation of middle-phase 18F-florbetaben positron emission tomography imaging using centiloid quantification and visual assessment
Background: 18F-florbetaben (FBB) positron emission tomography (PET) scan has been widely used in research and routine clinical practice. Most studies used late-phase (scanning from 90 to 110 min after injection) FBB scans to generate beta-amyloid accumulation data. The feasibility of middle-phase scan is seldom discussed. Using the middle-phase data can shorten the patients’ waiting between the injection and scan, and hospital can acquire more flexible schedule of routine scan. Methods: Paired middle-phase (60–80 min) FBB scans and standard (90–110 min) FBB scans were obtained from 27 subjects (12 neurodegenerative dementia, 8 mild cognitive impairment, 3 normal control, and 4 patients not suffering from neurodegenerative dementia). Standardized uptake value ratios (SUVRs) were calculated and converted to centiloid (CL) scale to investigate the impact on image quantification. CL pipeline validation were performed to build an equation converting the middle-phase data into equivalent standard scans. Cohen’s kappa of binary interpretation and brain amyloid plaque load (BAPL) score were also used to evaluate the intrareader agreement of the FBB image from the two protocols. Results: The middle-phase FBB SUVR showed an excellent correlation, which provided a linear regression equation of SUVRFBB60–80 = 0.88 × SUVRFBB90–110 + 0.07, with R2=0.98. The slope of the equation indicated that there was bias between the middle and standard acquisition. This can be converted into the CL scale using CL = 174.68 × SUVR − 166.39. Cohen’s kappa of binary interpretation and BAPL score were 1.0 (PConclusions: Our findings indicate that the middle-phase FBB protocol is feasible in clinical applications for scans that are at either end of beta-amyloid spectrum, which provides comparable semiquantitative results to standard scan. Patient’s waiting time between the injection and scan can be shortened.